期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 111, 期 1, 页码 7-13出版社
WILEY
DOI: 10.1002/jcb.22661
关键词
VITAMIN D; RICKETS; OSTEOMALACIA; BONE
资金
- National Institute of Health [K23DK073356, RO1 DK46974]
- MGH Physician-Scientist Development Award
- Boston Area Diabetes and Endocrinology Research Center
Vitamin D is a steroid pro-hormone, whose active metabolite binds the vitamin D receptor (VDR) which, in turn, binds to DNA sequences on target genes as a heterodimer with the retinoid-X receptor, resulting in regulation or gene expression. The vitamin D pro-hormone can be synthesized in the skin. in response to ultraviolet radiation; however, dietary sources have become increasingly important as a result or cultural changes over the past few centuries. Based on its initial discovery as an anti-rachitic factor, studies of the role of vitamin D and its receptor have largely focused on the skeleton. Investigations into the pathophysiologic basis and therapeutic responses of skeletal disorders associated with impaired vitamin D action have led to the identification or the molecular pathways Involved in hormone activation and regulation of gene expression by the liganded VDR. These studies have also demonstrated that the skeletal actions of the VDR and its ligand are largely redundant if normal mineral ion homeostasis can be maintained by other means. However, investigations in animal models with tissue-specific ablation of the VDR or the enzyme required km hormone activation have demonstrated novel actions in skeletal tissues The active vitamin D metabolite has been shown to have both paractine and endocrine actions in other tissues as well. J. Cell. Biochem. 111: 7-13, 2010. (C) 2010 Wilcy-Liss. Inc
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据